QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
FRA:QIA - Deutsche Boerse Ag - NL0015002CX3 - Common Stock - Currency: EUR
QIA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 15 industry peers in the Life Sciences Tools & Services industry. QIA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. QIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year QIA was profitable.
In the past year QIA had a positive cash flow from operations.
QIA had positive earnings in each of the past 5 years.
Each year in the past 5 years QIA had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.47%, QIA is doing worse than 60.00% of the companies in the same industry.
With a Return On Equity value of 2.34%, QIA is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
QIA's Return On Invested Capital of 7.09% is fine compared to the rest of the industry. QIA outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.09% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
QIA has a Profit Margin of 4.23%. This is comparable to the rest of the industry: QIA outperforms 46.67% of its industry peers.
QIA's Profit Margin has declined in the last couple of years.
The Operating Margin of QIA (24.85%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of QIA has declined.
QIA has a Gross Margin of 63.65%. This is amongst the best in the industry. QIA outperforms 93.33% of its industry peers.
In the last couple of years the Gross Margin of QIA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.85% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.65% |
OM growth 3Y-29.81%
OM growth 5Y-13.17%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-8.78%
GM growth 5Y-5.78%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
There is no outstanding debt for QIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 4.12 indicates that QIA is not in any danger for bankruptcy at the moment.
QIA has a Altman-Z score of 4.12. This is amongst the best in the industry. QIA outperforms 86.67% of its industry peers.
The Debt to FCF ratio of QIA is 2.77, which is a good value as it means it would take QIA, 2.77 years of fcf income to pay off all of its debts.
QIA's Debt to FCF ratio of 2.77 is amongst the best of the industry. QIA outperforms 93.33% of its industry peers.
QIA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
QIA has a better Debt to Equity ratio (0.38) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 4.12 |
ROIC/WACC0.96
WACC7.36%
2.3 Liquidity
QIA has a Current Ratio of 3.61. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of QIA (3.61) is better than 100.00% of its industry peers.
A Quick Ratio of 3.09 indicates that QIA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.09, QIA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.22% over the past year.
Measured over the past years, QIA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.25% on average per year.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.66%.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)4.22%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%10.91%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%2.36%
3.2 Future
The Earnings Per Share is expected to grow by 7.51% on average over the next years.
QIA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.27% yearly.
EPS Next Y5.89%
EPS Next 2Y7.19%
EPS Next 3Y7.84%
EPS Next 5Y7.51%
Revenue Next Year2.68%
Revenue Next 2Y4.58%
Revenue Next 3Y5.31%
Revenue Next 5Y8.27%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.61, the valuation of QIA can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of QIA indicates a rather cheap valuation: QIA is cheaper than 86.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.33, QIA is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 18.50, the valuation of QIA can be described as rather expensive.
QIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 66.67% of the companies in the same industry.
QIA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.61 | ||
| Fwd PE | 18.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 66.67% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 73.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.59 | ||
| EV/EBITDA | 12.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.33
PEG (5Y)2.38
EPS Next 2Y7.19%
EPS Next 3Y7.84%
5. Dividend
5.1 Amount
No dividends for QIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:QIA (4/23/2025, 3:56:04 PM)
37.66
+0.76 (+2.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap8.14B
Analysts75.83
Price Target46.35 (23.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)-5.57%
PT rev (3m)-7.08%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)2.04%
EPS NY rev (1m)-0.41%
EPS NY rev (3m)0.07%
Revenue NQ rev (1m)0.66%
Revenue NQ rev (3m)-2.49%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-2.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.61 | ||
| Fwd PE | 18.5 | ||
| P/S | 4.72 | ||
| P/FCF | 18.59 | ||
| P/OCF | 13.87 | ||
| P/B | 2.62 | ||
| P/tB | 11.14 | ||
| EV/EBITDA | 12.81 |
EPS(TTM)1.92
EY5.1%
EPS(NY)2.04
Fwd EY5.41%
FCF(TTM)2.03
FCFY5.38%
OCF(TTM)2.72
OCFY7.21%
SpS7.98
BVpS14.38
TBVpS3.38
PEG (NY)3.33
PEG (5Y)2.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.55% | ||
| ROIC | 7.09% | ||
| ROICexc | 9.14% | ||
| ROICexgc | 28.87% | ||
| OM | 24.85% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.65% | ||
| FCFM | 25.39% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-29.81%
OM growth 5Y-13.17%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-8.78%
GM growth 5Y-5.78%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.93 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.93% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 4.12 |
F-Score7
WACC7.36%
ROIC/WACC0.96
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)4.22%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%10.91%
EPS Next Y5.89%
EPS Next 2Y7.19%
EPS Next 3Y7.84%
EPS Next 5Y7.51%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%2.36%
Revenue Next Year2.68%
Revenue Next 2Y4.58%
Revenue Next 3Y5.31%
Revenue Next 5Y8.27%
EBIT growth 1Y10.42%
EBIT growth 3Y-32.77%
EBIT growth 5Y-8.55%
EBIT Next Year56.47%
EBIT Next 3Y22.36%
EBIT Next 5Y16.09%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%